Back | Next |
home / stock / avxl / avxl message board
Subject | By | Source | When |
---|---|---|---|
I'm in Montreal. I believe he means ND | LakeshoreLeo1953 | investorshub | 07/19/2024 1:50:20 PM |
Dr Sabbagh re-posted this message on Linked in | Hosai | investorshub | 07/19/2024 1:47:29 PM |
I saw the Notre Dame before it burned | Investor2014 | investorshub | 07/19/2024 1:35:07 PM |
Yes and still down 31.50% from max over | Investor2014 | investorshub | 07/19/2024 1:32:06 PM |
The Notre Dame cathedral is very impressive. I | ignatiusrielly35 | investorshub | 07/19/2024 1:29:33 PM |
That actually has been an issue when Missling presenting. | LakeshoreLeo1953 | investorshub | 07/19/2024 1:28:57 PM |
Among the Ouija Boards, Home Equity Loans, and | LakeshoreLeo1953 | investorshub | 07/19/2024 1:25:36 PM |
Just a quick look BEFORE the opening: | sab63090 | investorshub | 07/19/2024 11:21:14 AM |
I think a stock should be looked at | sab63090 | investorshub | 07/19/2024 11:07:46 AM |
Tom: Thanks for your detailed analysis, I just logged | sab63090 | investorshub | 07/19/2024 10:59:42 AM |
Thanks Oral presentations are reserved for substantial data not | rx7171 | investorshub | 07/19/2024 5:46:02 AM |
These both appear to be oral presentations. | georgejjl | investorshub | 07/19/2024 5:35:58 AM |
Are the 28 and 29 presentations oral or posters? | rx7171 | investorshub | 07/19/2024 5:18:53 AM |
Anavexs Innovative Alzheimers Therapy Blarcamesine Has Been Approved | georgejjl | investorshub | 07/19/2024 5:01:03 AM |
I always skip his posts. His analysis are | jav0033 | investorshub | 07/19/2024 3:23:55 AM |
Exhibit 473 | frrol | investorshub | 07/19/2024 1:15:16 AM |
Thanks for the clarification. Do you happen to | abew4me | investorshub | 07/19/2024 12:45:03 AM |
You should consider the XBI in your analysis. | ignatiusrielly35 | investorshub | 07/19/2024 12:12:55 AM |
You have about 20 ifs in your analysis. | poguemahone | investorshub | 07/19/2024 12:02:43 AM |
What price did today ... | 123tom | investorshub | 07/18/2024 10:44:57 PM |
News, Short Squeeze, Breakout and More Instantly...
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
Oral, once daily blarcamesine significantly slowed clinical decline for early Alzheimer's disease patients with good comparative safety profile and no associated neuroimaging adverse events Clinical benefit of blarcamesine consistently observed for both 30 mg and 50 mg treatment groups ...
2024-07-18 02:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental and neuropsyc...